Olympus and Grundium Partner to Make Digital Pathology More Accessible

Olympus and Grundium Ltd. are collaborating to combine their expertise in microscopy optics and digital imaging to benefit pathology. Grundium has incorporated Olympus’ high-performance X Line™ objectives into its Ocus® portable single slide scanners to enable convenient creation and sharing of high-quality digital slides.

Grundium’s Ocus single slide scanner with integrated Olympus X Line high-performance objective makes digital pathology more accessible to researchers and produces digital slides with high color accuracy for remote consultation and evaluation. Image Credit: Olympus

The combined solution brings flexibility and reliability to pathologists’ remote consultations. In addition, as part of the partnership, Olympus now offers the Ocus product line with integrated X Line objectives across Europe and North America.

Increasing Need for Remote Collaboration Tools

Consultation and collaboration with colleagues have always been important aspects of pathology. Now, with telework on the rise, pathologists require agile solutions enabling them to share their slides, without concerns about image quality or cumbersome methods.

Truly Portable and Collaborative Telepathology

With the addition of Grundium’ Ocus single slide scanners, Olympus expands its range of digital pathology solutions. A cost-effective telepathology instrument, Ocus scanners accelerate workflows for applications requiring peer consultation, including intraoperative frozen section review, Rapid On-Site Evaluation (ROSE) and second opinions. Pathologists can use the Ocus scanner’s high portability and wireless connectivity to rapidly scan and share slides from any location. This flexibility enables experts to immediately evaluate samples remotely.

High-Quality Digital Slides to Assist Analysis

Integrated into Ocus scanners, X Line objectives’ advanced optical performance optimizes the quality of the digital slides produced. Fabricated using a proprietary lens-polishing technology, X Line objectives are the culmination of Olympus’ more than 100 years of optical design and manufacturing experience. Offering a high numerical aperture (NA), improved image flatness, and a wide chromatic correction range, X Line objectives provide the brightness, resolution, and color accuracy that pathology requires. To learn more about X Line objectives, visit www.olympus-lifescience.com/en/resources/white-papers/xline_high-performance_objectives.

Improved Customer Support

In addition to distributing Ocus scanners, Olympus will now also provide local sales and after-sales support for those equipped with X Line objectives in Europe and North America.

The partnership between Olympus and Grundium not only provides a practical and affordable digital pathology solution for today, but also sows the potential to innovate new and better imaging solutions for tomorrow.

“Working with Olympus has been very easy from the start. It feels great to be making an impact on digital pathology together. Grundium Ocus® microscope scanners combined with top-level Olympus optics are a great fit to enable medical professionals to work faster and easier,” says Davide D’Incau, Grundium Sales Director.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Evident Corporation - NDT. (2021, July 21). Olympus and Grundium Partner to Make Digital Pathology More Accessible. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=56522.

  • MLA

    Evident Corporation - NDT. "Olympus and Grundium Partner to Make Digital Pathology More Accessible". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=56522>.

  • Chicago

    Evident Corporation - NDT. "Olympus and Grundium Partner to Make Digital Pathology More Accessible". AZoM. https://www.azom.com/news.aspx?newsID=56522. (accessed November 21, 2024).

  • Harvard

    Evident Corporation - NDT. 2021. Olympus and Grundium Partner to Make Digital Pathology More Accessible. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=56522.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.